Company Filing History:

6 out of 712

The Rockefeller University

The Scripps Research Institute

patents

4. 1 out of 27

The Rockfeller University

patents

5. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2002

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6495332 - Methods and compositions for ameliorating the symptoms of sepsis (2002-12-17),

2. 6297049 - Methods and compositions for ameliorating the symptoms of sepsis (2001-10-02),

3. 6045795 - Methods and compositions for ameliorating the symptoms of sepsis (2000-04-04),

4. 5932536 - Compositions for neutralization of lipopolysaccharides (1999-08-03),

5. 5928624 - Compositions for neutralization of lipopolysaccharides (1999-07-27),

6. 5869055 - Anti-inflammatory CD14 polypeptides (1999-02-09),

7. 5767243 - Afamin: a human serum albumin-like protein (1998-06-16),

8. 5766593 - Anti-inflammatory CD14 peptides (1998-06-16),

9. 5730980 - Methods and compositions for ameliorating the symptoms of sepsis (1998-03-24),

10. 5652352 - Afamin: a human serum albumin-like gene (1997-07-29),

11. 5436321 - Antibodies to the lipopolysaccharide bonding opsonin septin (1995-07-25),

12. 5322699 - Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) (1994-06-21),

13. 5147637 - Method of inhibiting the influx of leukocytes into organs during sepsis (1992-09-15),

Title: The Innovations of Samuel D Wright

Introduction

Samuel D Wright is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of medical science, particularly in the treatment of sepsis. With a total of 13 patents to his name, Wright's work has the potential to impact patient care and treatment methodologies.

Latest Patents

One of his latest patents focuses on methods and compositions for ameliorating the symptoms of sepsis. This invention involves a method of treating sepsis by administering a therapeutically effective amount of anti-CD14 antibody molecules. Additionally, it contemplates a therapeutic composition comprising these antibody molecules in a pharmaceutically acceptable excipient. This innovative approach aims to provide new avenues for treating a condition that affects many patients worldwide.

Career Highlights

Throughout his career, Samuel D Wright has worked with prestigious institutions, including The Rockefeller University and Amgen Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Wright has collaborated with esteemed colleagues such as Richard J Ulevitch and Peter S Tobias. These partnerships have likely enriched his research and innovation processes, leading to the development of impactful medical solutions.

Conclusion

Samuel D Wright's contributions to the field of medical science through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative methods for treating sepsis represent a significant advancement in medical technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.